전남대학교 중앙도서관

Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial.

학술저널

issue: Lancet (London, England) [Lancet] 2024 Jun 01; Vol. 403 (10442), pp. 2405-2415. Date of Electronic Publication: 2024 May 16.
Author: Parker CC; The Royal Marsden NHS Foundation Trust, London, UK; The Institute of Cancer Research, London, UK.
Clarke NW; Department of Urology, The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, University of Manchester, Manchester, UK; Department of Urology, Salford Royal Hospital, Salford, UK.
Cook AD; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK.
Kynaston H; Division of Cancer and Genetics, Cardiff University Medical School, Cardiff, UK.
Catton CN; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
Cross WR; Department of Urology, St James's University Hospital, Leeds, UK.
Petersen PM; Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Persad RA; Department of Urology, Bristol Urological Institute, Bristol, UK.
Saad F; Department of Urology, Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada.
Bower LC; The Royal Marsden NHS Foundation Trust, London, UK; The Institute of Cancer Research, London, UK; Guy's and St Thomas' NHS Foundation Trust, London, UK.
Logue J; Department of Urology, The Christie NHS Foundation Trust, Manchester, UK.
Payne H; The Prostate Centre, London, UK.
Forcat S; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK.
Goldstein C; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK.
Murphy C; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK.
Anderson J; Department of Clinical Oncology, St James's University Hospital, Leeds, UK.
Barkati M; Department of Radiation Oncology, Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada.
Bottomley DM; Department of Clinical Oncology, St James's University Hospital, Leeds, UK.
Branagan J; Northampton General Hospital, Northampton, UK.
Choudhury A; Department of Urology, The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, University of Manchester, Manchester, UK.
Chung PWM; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada.
Cogley L; Derriford Hospital, Plymouth, UK.
Goh CL; Royal Surrey Hospital, Guildford, UK.
Hoskin P; Division of Cancer Sciences, University of Manchester, Manchester, UK; Mount Vernon Cancer Centre, Northwood, UK.
Khoo V; The Royal Marsden NHS Foundation Trust, London, UK; The Institute of Cancer Research, London, UK.
Malone SC; The Ottawa Hospital, University of Ottawa, Ottawa, ON, Canada.
Masters L; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK.
Morris SL; Guy's and St Thomas' NHS Foundation Trust, London, UK.
Nabid A; Service de Radio-Oncologie, Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, QC, Canada.
Ong AD; Max Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada.
Raman R; Kent Oncology Centre, Kent and Canterbury Hospital, Canterbury, UK.
Tarver KL; Department of Oncology, Queen's Hospital, Romford, UK.
Tree AC; The Royal Marsden NHS Foundation Trust, London, UK; The Institute of Cancer Research, London, UK.
Worlding J; University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK.
Wylie JP; Department of Urology, The Christie NHS Foundation Trust, Manchester, UK.
Zarkar AM; Department of Oncology, University Hospitals Birmingham, Birmingham, UK.
Parulekar WR; Canadian Cancer Trials Group, Queen's University, Kingston, ON, Canada.
Parmar MKB; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK.
Sydes MR; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK. Electronic address: mrcctu.radicals@ucl.ac.uk.
DB Label: Database : MEDLINE

원문보기: Full Text (ScienceDirect) Full Text (Clinical Key) 등재 - SCOPUS 조회 - Impact Factor (JCR)

링크메뉴

주메뉴

전자자료 상세검색

전자자료 상세검색

전체선택